Minimal Oxygen Supplementation Recommended for Most Inpatients
By HospiMedica International staff writers Posted on 13 Nov 2018 |
A new guidance statement reports that supplemental oxygen is not always indicated for acutely ill patients, and may contribute to higher mortality.
An expert panel from McMaster University (Hamilton, ON, Canada), Stellenbosch University (SU, South Africa), University Hospitals of Geneva (Switzerland), and other institutions convened to evaluated a recent systematic review and meta-analysis of 25 randomized controlled trials in order to develop recommendations for supplemental oxygen therapy in critically ill patients, surgical patients with sepsis, hospitalized patients, or patients en-route to hospital in an ambulance. Postoperative, obstetric, and pediatric patients were not included in the review.
The systematic review, which was published in The Lancet in April 2018, found that supplemental oxygen in inpatients with normal oxygen saturation increases mortality, and recommended that oxygen should be administered conservatively. The international panel of experts made several key recommendations, including maintaining peripheral oxygen saturation (SpO2) at or below 96% in patients on supplemental oxygen; in patients with acute myocardial infarction (MI) or stroke, oxygen should not be administered if the initial SpO2 is higher 92%. The guidance recommendations were published on October 24, 2018, in BMJ.
“It is a longstanding cultural norm to provide supplemental oxygen to sick patients, regardless of their blood oxygen saturation. A recent systematic review and meta-analysis has shown that too much supplemental oxygen increases mortality for medical patients in hospital,” concluded lead author Reed Siemieniuk, MD, PhD, of McMaster University, and colleagues. “A target SpO2 range of 90-94% seems reasonable for most patients, and 88-92% for patients at risk of hypercapnic respiratory failure seems wide enough to allow for normal fluctuation, and is likely low enough to avoid harm.”
The reasons as to why excessive supplemental oxygen increases mortality remain uncertain. Excessive oxygen can lead to reduced cardiac output, vasoconstriction, inflammation, and oxidative stress. In addition, excessive oxygen might lead to falsely reassuring SpO2 values and make it difficult to recognize when a patient’s condition worsens.
Related Links:
McMaster University
Stellenbosch University
University Hospitals of Geneva
An expert panel from McMaster University (Hamilton, ON, Canada), Stellenbosch University (SU, South Africa), University Hospitals of Geneva (Switzerland), and other institutions convened to evaluated a recent systematic review and meta-analysis of 25 randomized controlled trials in order to develop recommendations for supplemental oxygen therapy in critically ill patients, surgical patients with sepsis, hospitalized patients, or patients en-route to hospital in an ambulance. Postoperative, obstetric, and pediatric patients were not included in the review.
The systematic review, which was published in The Lancet in April 2018, found that supplemental oxygen in inpatients with normal oxygen saturation increases mortality, and recommended that oxygen should be administered conservatively. The international panel of experts made several key recommendations, including maintaining peripheral oxygen saturation (SpO2) at or below 96% in patients on supplemental oxygen; in patients with acute myocardial infarction (MI) or stroke, oxygen should not be administered if the initial SpO2 is higher 92%. The guidance recommendations were published on October 24, 2018, in BMJ.
“It is a longstanding cultural norm to provide supplemental oxygen to sick patients, regardless of their blood oxygen saturation. A recent systematic review and meta-analysis has shown that too much supplemental oxygen increases mortality for medical patients in hospital,” concluded lead author Reed Siemieniuk, MD, PhD, of McMaster University, and colleagues. “A target SpO2 range of 90-94% seems reasonable for most patients, and 88-92% for patients at risk of hypercapnic respiratory failure seems wide enough to allow for normal fluctuation, and is likely low enough to avoid harm.”
The reasons as to why excessive supplemental oxygen increases mortality remain uncertain. Excessive oxygen can lead to reduced cardiac output, vasoconstriction, inflammation, and oxidative stress. In addition, excessive oxygen might lead to falsely reassuring SpO2 values and make it difficult to recognize when a patient’s condition worsens.
Related Links:
McMaster University
Stellenbosch University
University Hospitals of Geneva
Latest Critical Care News
- AI Doubles Medical Professionals’ Accuracy in Reading EEG Charts of ICU Patients
- Flexible Device Enables Sweat Gland Stimulation and Simultaneous Biosensing
- WHO Publishes First Global Guidelines to Reduce Bloodstream Infections from Catheter Use
- Innovative Material Paves Way for Next-Generation Wearable Devices
- Wireless Electronic Suture Enables Postoperative Long-Term Monitoring Of Soft Tissue
- Transcatheter Valve Replacement Outcomes Similar To Surgery, Finds Study
- Revascularization Improves Life Quality in Chronic Limb-Threatening Ischemia, Finds Study
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergency Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD